1 Min Read
June 19 (Reuters) - Horizon Pharma Plc
* Horizon Pharma Plc announces Health Canada approval of Procysbi™ (cysteamine delayed-release capsules) for the treatment of nephropathic cystinosis Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.